• Story Reviews
  • News Release Reviews
  • Blog
  • Podcasts
  • About Us
  • Toolkit for journalists and consumers
  • Contact
  • Newsletter Signup
HealthNewsReview.org HealthNewsReview.org HealthNewsReview.org
  • 2616 Story Reviews
  • 606 News Release Reviews
  • 2944 Blog Posts
  • Home
  • Story Reviews
  • News Release Reviews
  • Blog
  • Podcasts
  • About Us
    • Editorial Team
    • What We Review and How
    • Review Criteria
    • How Is the Star Score Determined?
    • Our Comments Policy
    • Accolades for HealthNewsReview.org
    • Talks, Workshops & Presentations
  • Toolkit
    • Tips for Analyzing Studies & Health Care Claims
    • Just for Journalists: Writing Tips
    • Stories of Patient Harm from Misleading Media
    • Pre-publication News Release Review
    • Health News Watchdog podcasts
    • News Sites & Blogs We Like
    • List of Industry-Independent Experts
    • Links to Other Resources
  • Contact

Search Results for " pfizer national press foundation"

11/21/2019

Another conflicted all-expenses-paid junket offer by the National Press Foundation

Two months from now we will be in mid-winter, late January. How about four days in warm, sunny West Palm Beach, Florida? All-expenses-paid. How inviting. But how troubling.  Once again. An email was sent to journalists this week announcing this junket funded by Bayer, a multinational drug company.  Bayer markets a number of cardiovascular drugs […]

3/10/2014

Another conflicted journalism training event by the National Press Foundation

On the Knight Science Journalism Tracker, Paul Raeburn writes, “Beware the National Press Foundation’s ‘Tips for High-Fidelity Science Reporting’ webinar.” The announcement by the National Press Foundation states: Any journalist who wants to improve her or his work on scientific topics will benefit from this webinar. It will highlight common challenges in communicating science and […]

9/16/2011

Journalists weigh in on Pfizer-pfunded & other pharma-phunded journalism “events”

Andrew Holtz updates us on what he calls Pfizer’s “attempts to co-opt journalists” by sponsoring various journalism “events.” As Holtz notes, it’s an old and sore subject with me. Several concerned journalists within the past two years have criticized the National Press Foundation (NPF) for accepting Pfizer money for all-expenses-paid trips for journalists to come […]

10 10/13/2010

Industry influence is "an infection" – international criticism of Pfizer-funded journalism workshops

Next week, the National Press Foundation offers an “all-expenses-paid, educational program on cancer issues” for journalists, with all expenses paid by Pfizer. I’ve written several times about my criticism of this approach. The National Press Foundation has offered to let me speak at next week’s event or at a subsequent all-expenses-paid program for journalists on […]

9/27/2010

Pfizer – a Pfriend of Journalists?

Last week journalists got an email from the National Press Foundation (NPF) inviting them to apply for another all-expenses-paid program for which drug company Pfizer is contributing some of the funding. The topic this time is Alzheimer’s Disease – another field in which Pfizer makes products. Readers of this blog know that I have led […]

8/23/2010

Here we go again with Pfizer-funded cancer seminar for journalists

I knew about it. But I wasn’t going to write about it because I did last year and my criticism apparently went nowhere. But then a former journalism student, Emma Carew, now at the Star Tribune, tweeted me this morning about the latest round of Pfizer-funded cancer seminars at the National Press Foundation in Washington, […]

8/5/2020

Drug company influence on journalism

Many times through the years, HealthNewsReview.org has criticized the National Press Foundation in Washington, DC, for accepting drug company funding for journalism training.  (See articles from June 2009, July 2009, August 2010, September 2010, October 2010, March 2014, March 2015, December 2015, November 2019. I may have missed a few, but you get the picture.) They’re doing it […]

1
12/18/2018

6 reasons journalists should just say no to Mayo Clinic’s latest journalism ‘residency’ program

Craving a trip to Florida in February? If you’re a journalist, the Mayo Clinic has you covered. Once again Mayo is extending an offer to educate health care journalists, this time with what it’s calling a “residency” scheduled for Feb. 24-28 at the Mayo Clinic in Jacksonville, Fla. It’s described as “a behind-the-scenes, in-depth look […]

pharma op-eds
10/9/2017

‘Ethical bordellos:’ Op-eds don’t always disclose Big Pharma conflicts of interest

Drug companies have been promoting their views on the nation’s op-ed pages via commentary writers who come across as neutral-sounding experts, and editors don’t always call out these industry mouthpieces for what they are. Pharma-friendly guest columns have appeared on editorial pages around the country without disclosure of the authors’ drug industry ties, including the […]

2
the Alliance for Patient Access
10/2/2017

Non-profit Alliance for Patient Access uses journalists and politicians to push Big Pharma’s agenda

In an era of widespread calls for action to tame skyrocketing prescription drug costs, one organization consistently opposes measures to rein them in: the Alliance for Patient Access (AfPA). The AfPA claims it’s trying to ensure patients have access to FDA-approved therapies. However, its track record shows it pushes platforms that help drug companies’ bottom […]

7
6/12/2017

Conflicts of interest in health care journalism. Who’s watching the watchdogs? We are. Part 1 of 3

Ben Harder, a journalist with US News & World Report, recently tweeted, “Pharma ads subsidize many health reporters’ salaries.” Elisabeth Rosenthal, who now heads Kaiser Health News after a long career with the New York Times, tweeted in that same discussion, “Many of my articles in the NYT carried pop-up ads for pharma. Infuriating.” Many […]

11
12/6/2016

With media watchdogs on the sidelines, pharma-funded advocacy groups pushed Cures Act to the finish line  

The passage of the 21st Century Cures Act, which sailed through the House of Representatives last week on its way to a future White House signing ceremony, is due in no small measure to the activities of hundreds of patient advocacy groups and assorted other stakeholders that worked in overdrive the past two years pushing […]

prop 61 ballot initiative
10/27/2016

High stakes in ballot battle over rising prescription drug costs

Big PhRMA is worried. It has poured an unprecedented amount of cash into defeating a ballot initiative that would take a baby step toward controlling sky-high prices of prescription drugs, for which Americans have spent seven percent more this year than they did in 2015. It was the largest increase in 24 years. Drug makers and […]

4
12/9/2015

Is it ok for journalists to attend Bayer-funded training on new cancer treatments?

Once again the National Press Foundation’s programs are raising conflict of interest questions for journalists. This time the NPF is sponsoring its seventh training session on covering cancer this month in Washington, and in February there will be another training event on obesity held in Phoenix. Both are enticing. The prospect of lots of story ideas, reporting […]

2 3/23/2015

Sponsored journalist training on “precision medicine”: Zeroing in on a conflict of interest

The following is a guest post from Andrew Holtz, one of our longtime contributors, my former colleague at CNN, and a past president of the Association of Health Care Journalists.  This is at least the sixth time that we have addressed National Press Foundation workshop funding on this site. ———————— The question came from multiple […]

  • 1
  • 2
  • Next »

Toolkit

Tips & Resources for Analyzing Health Care Claims

Surrogate markers may not tell the whole story

Screening: How overdiagnosis and other harms can undermine the benefits

A place to tell stories of patient harm from misleading media

View More

Toolkit

Institutional Home

University of Minnesota - School of Public Health
  • Home
  • Story Reviews
  • News Release Reviews
  • Blog
  • About Us
  • Toolkit
  • Contact

Copyright © 2022 HealthNewsReview.org